Guangdong Tainkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 13th meeting of the 5th Board of Directors on January 28, 2026, and the first extraordinary general meeting of shareholders on February 13, 2026, where it reviewed and approved the proposal regarding the "Draft of Guangdong Tainkang Pharmaceutical Co., Ltd. 2026 Employee Stock Ownership Plan" and related proposals, agreeing to implement the 2026 Employee Stock Ownership Plan. On February 13, 2026, the Company held the 14th meeting of the 5th Board of Directors, where it reviewed and approved the proposal regarding the "Revised Draft of Guangdong Tainkang Pharmaceutical Co., Ltd. 2026 Employee Stock Ownership Plan" and related proposals. The Board of Directors made revis
301263SZSE
Announcement on the Progress of the 2026 Employee Stock Ownership Plan
✨ AI Summary
Guangdong Tainkang Pharmaceutical Co., Ltd. has approved the implementation of its 2026 Employee Stock Ownership Plan. The plan was discussed in board meetings on January 28 and February 13, 2026. A securities trading account for the plan was opened on February 26, 2026, but as of the announcement date, no company stocks have been held under this plan. The company will continue to monitor the plan's progress and fulfill disclosure obligations.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.